Browse Category

Investment Strategies News 14 October 2025 - 16 October 2025

Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Financial Group’s logo displayed on the trading floor of the New York Stock Exchange. The stock has seesawed amid strong earnings and fallout from a client’s bankruptcy. reuters.com tradingview.com Earnings Soar on Dealmaking Rebound Jefferies’ latest quarterly report showcased
Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion Pharmaceuticals (NASDAQ: RXRX) is a Salt Lake City–based clinical-stage “TechBio” biotech that uses AI, automation and massive biological datasets to speed drug discovery ts2.tech. In early October 2025 the stock showed wild swings: it plunged to the mid-$5s then
Bull Run or Bubble? Investors Eye New Highs as EUR/USD Rallies and Fed Prepares Cuts

Bull Run or Bubble? Investors Eye New Highs as EUR/USD Rallies and Fed Prepares Cuts

Global markets were buoyed this week by better-than-feared news on several fronts. After a rough September, U.S. bank earnings beat estimates: Morgan Stanley and Bank of America both delivered upside surprises, which helped calm trade-war jitters reuters.com. European stocks likewise
Astera Labs (ALAB) Stock Plummets After AMD-Oracle AI Deal – What Investors Should Know

Astera Labs (ALAB) Stock Plummets After AMD-Oracle AI Deal – What Investors Should Know

Astera’s stock has been volatile on recent AI infrastructure news. After surging on an earlier AMD/OpenAI deal – Citi analysts noted Astera’s shares “popped 10%” after that announcement investopedia.com – the Oct 14 AMD-Oracle GPU deal triggered a sharp pullback
1 81 82 83 84 85 88
Go toTop